Literature DB >> 10071926

Molecular properties of a hemagglutinin purified from type A Clostridium botulinum.

S K Sharma1, F N Fu, B R Singh.   

Abstract

Clostridium botulinum causes the food poisoning disease botulism by producing botulinum neurotoxin, the most potent toxin known. The neurotoxin is produced along with a group of neurotoxin-associated proteins, or NAPs, which protect it from the low pH and proteases of the gastrointestinal tract. Recently, we isolated one of the major components of NAPs, a 33-kDa hemagglutinin (Hn-33) [Fu et al. (1998), J. Protein Chem. 17, 53-60]. In this study, we present molecular properties of Hn-33 derived from several biochemical and biophysical techniques. Hn-33 in pure form requires a 66-fold lower concentration of sugar inhibition of its hemagglutination activity than in its complexed form with the neurotoxin and other NAPs. However, its protease resistance is not affected by sugar binding. Based on FT-IR and circular dichroism (CD) analysis, Hn-33 is a predominantly beta-sheet protein (74-77%). Hn-33 analysis by laser desorption mass spectrometry and size exclusion column chromatography reveals that it exists predominantly in a dimeric form in the aqueous solution. Even a very low concentration of SDS (0.05%) irreversibly destroyed the biological activity of Hn-33 by changing its secondary structure as revealed by far-UV CD analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071926     DOI: 10.1023/a:1020691215056

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  6 in total

1.  Detection and confirmation of Clostridium botulinum in water used for cooling at a plant producing low-acid canned foods.

Authors:  Amita Sachdeva; Stephanie L H Defibaugh-Chávez; James B Day; Donald Zink; Shashi K Sharma
Journal:  Appl Environ Microbiol       Date:  2010-10-01       Impact factor: 4.792

2.  Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains.

Authors:  Giovanna Franciosa; Francesca Floridi; Antonella Maugliani; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

3.  Flu-like symptoms and associated immunological response following therapy with botulinum toxins.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic; Jordan Feld
Journal:  Neurotox Res       Date:  2013-05-16       Impact factor: 3.911

4.  Responses of Azospirillum brasilense to nitrogen deficiency and to wheat lectin: a diffuse reflectance infrared fourier transform (DRIFT) spectroscopic study.

Authors:  Alexander A Kamnev; Julia N Sadovnikova; Petros A Tarantilis; Moschos G Polissiou; Lyudmila P Antonyuk
Journal:  Microb Ecol       Date:  2008-04-25       Impact factor: 4.552

Review 5.  Clinical relevance of botulinum toxin immunogenicity.

Authors:  Reiner Benecke
Journal:  BioDrugs       Date:  2012-04-01       Impact factor: 5.807

6.  Cloning, expression, purification, and characterization of biologically active recombinant hemagglutinin-33, type A botulinum neurotoxin associated protein.

Authors:  Yu Zhou; Sowmya Paturi; Paul Lindo; Suzanne M Shoesmith; Bal Ram Singh
Journal:  Protein J       Date:  2007-01       Impact factor: 4.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.